Chengdu Olymvax Biopharmaceuticals Inc. Class ASSE: 688319

2025 Semi-annual Report

Aug 29, 2025 · Issued by Chengdu Olymvax Biopharmaceuticals Inc. Class A via Shanghai Stock Exchange

2025 Semi-annual Report

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment